L.E.A.F Pharmaceuticals
Gulph Mills, US · Founded 2014 · Delaware LLC
Founders & leadership
EF
Erin FridayNamed on SEC filing
MG
Mickey GillNamed on SEC filing
AA
Antoine AwadNamed on SEC filing
VM
Victor MoyoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$40.4M disclosed across 1 round · 2017
▶$40.4MraisedAug 2017 · 4 investors · PharmaceuticalsRule 506(b)
▶$40.4MraisedAug 2017 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Erin FridayExecutive Officer
- Mickey GillExecutive Officer
- Antoine AwadExecutive Officer
- Victor MoyoExecutive Officer
- Offering amount
- $40.4M
- Amount sold
- $40.4M
- Minimum investment
- $50K
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has L.E.A.F Pharmaceuticals raised?
- L.E.A.F Pharmaceuticals has disclosed $40.4M raised across 1 round.
- Where is L.E.A.F Pharmaceuticals headquartered?
- L.E.A.F Pharmaceuticals is headquartered in Gulph Mills, US.